China NMPA Product Recall - Monitor defibrillator

Philips Medical Systems, in conjunction with its agent Philips (China) Investment Co., Ltd., initiated a voluntary Class II recall for specific monitored defibrillators (Registration Certificate No. 20163214004). This action was reported to the National Medical Products Administration (NMPA) on October 29, 2018, and publicly announced on November 7, 2018. The recall addresses a critical safety concern stemming from potentially defective components in the lithium-ion batteries of the M3538A model defibrillators. These faulty components could prevent the battery from charging or powering the device, potentially hindering its operation, particularly if a secondary battery or external power source is not available. Additionally, the battery's LED status indicator might fail, making it difficult to detect the malfunction. While the recall is global, the document explicitly states that the affected batches were not sold in China. Consequently, specific corrective actions and handling methods for the Chinese market were deemed 'Not Applicable,' as no units requiring intervention were distributed within the country.